Hematological Complications in Obstetrics, Pregnancy, and Gynecology: Hereditary and acquired thrombophilia in pregnancy

作者: Rodger L. M.D. Bick , William F. Jr. Baker

DOI: 10.1017/CBO9780511526978.006

关键词:

摘要: Introduction Thrombophilia in pregnancy represents a challenging problem for obstetricians, reproductive medicine specialists and hematologists. Normal is known to be associated with an enhanced risk of deep vein thrombosis (DVT) pulmonary embolus (PE). When combined thrombophilic disorder, this significantly enhanced, usually considered about 5–8-fold elevated normal pregnant women, addition thrombophilia, or other clinically significant factor, requires particular attention avoid unnecessary fetal loss maternal morbidity mortality. obstetrics not only risks DVT PE, but also recurrent miscarriage syndrome, infertility, stillborn births, eclampsia intrauterine growth retardation, pre-eclampsia, frank eclampsia, HELLP syndrome abruption, the additional usual thrombohemorrhagic complications, such as disseminated intravascular coagulation. Indeed many women undiagnosed thrombophilia will experience their first clinical manifestation when – without PE. In addition, patients who have had prior DVT/PE harbor thus emphasizing importance adequate investigation suggestive personal family history warrants. This chapter summarizes (1) antithrombotic approaches factors, (2) thrombophilias concern obstetrician, specialist hematologist. treatment discussions recommendations discussed general then, necessary, any disorder. It must appreciated course patients, particularly during pregnancy, highly dynamic.

参考文章(374)
Stemerman Mb, Vascular intimal components: precursors of thrombosis. Progress in hemostasis and thrombosis. ,vol. 2, pp. 1- 47 ,(1974)
Wight Tn, Vessel proteoglycans and thrombogenesis. Progress in hemostasis and thrombosis. ,vol. 5, pp. 1- 39 ,(1980)
E Grau, A Oliver, J Félez, P Barceló, C Fernandez, J A Ballarin, J Fontcuberta, M L I Rutilant, Plasma and Urinary Heparin Cofactor II Levels in Patients with Nephrotic Syndrome Thrombosis and Haemostasis. ,vol. 60, pp. 137- 140 ,(1988) , 10.1055/S-0038-1647017
Clauvel Jp, Angles-Cano E, Sultan Y, Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage. Journal of Laboratory and Clinical Medicine. ,vol. 94, pp. 312- ,(1979)
Rodger L. Bick, William F. Baker, Anticardiolipin Antibodies and Thrombosis Hematology/Oncology Clinics of North America. ,vol. 6, pp. 1287- 1299 ,(1992) , 10.1016/S0889-8588(18)30275-2
A. S. Janoff, J. Rauch, The nature of antiphospholipid antibodies. The Journal of Rheumatology. ,vol. 19, pp. 1782- 1785 ,(1992)
Francesco Violi, Domenico Ferro, Claudio Quintarelli, Cesare Alessandri, Mirella Saliola, Guido Valesini, Francesco Balsano, Dilute aPTT prolongation by antiphospholipid antibodies in patients with liver cirrhosis. Thrombosis and Haemostasis. ,vol. 63, pp. 183- 186 ,(1990) , 10.1055/S-0038-1645192
K B Heller, R L Bick, J Madden, A Toofanian, Recurrent miscarriage: causes, evaluation, and treatment. Medscape women's health. ,vol. 3, pp. 2- 2 ,(1998)
Rozen R, Molecular genetic aspects of hyperhomocysteinemia and its relation to folic acid. Clinical and Investigative Medicine. ,vol. 19, pp. 171- 178 ,(1996)
Mark Levine, Nonhemorrhagic complications of anticoagulant therapy. Seminars in Thrombosis and Hemostasis. ,vol. 12, pp. 63- 66 ,(1986) , 10.1055/S-2007-1003535